Claude Mambo Muvunyi
Claude Mambo Muvunyi is an expert in Infectiology at Rwanda Biomedical Center (Rwanda). Claude Mambo Muvunyi has authored 206 publications, the most recent in 2026, and is an investigator in 5 clinical trials, 2 of them ongoing. SLR score: 836 (community average: 125). How the SLR is computed.
LeadR Profile
Infectiology
Subspecialties: Public Health - Biochemistry
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2009 - 2026
Number : 206
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Genome-wide association study of human papillomavirus infection and persistence in women living with HIV in Rwanda. PMID 42934691 — genes, genome-wide association study, genome, alphapapillomavirus, papillomavirus infections, infections, human papillomavirus viruses | Infect Agent Cancer | 2026 | 0 |
| Global and regional burden of measles and vaccine coverage among children under 5 years, 1990-2023: a Global Burden of Disease Study. PMID 42907529 — mortality, vaccines, incidence, measles, global burden of disease, cost of illness, child | Nat Med Top journal | 2026 | 2 |
| Global, regional, and national burden of tuberculosis and multidrug-resistant tuberculosis by HIV status, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023. PMID 42385762 — fasting, mortality, tuberculosis, multidrug-resistant, incidence, global health, pharmaceutical preparations, global burden of disease, hiv, tuberculosis, risk factors, morbidity, cost of illness, smoking, communicable diseases, plasma | Lancet Infect Dis Top journal | 2026 | 2 |
| National prioritisation of zoonotic diseases in Rwanda: a One Health modified Delphi consensus study. PMID 42851733 — exercise, zoonoses | BMJ Public Health | 2026 | 0 |
| Global, Regional, and National Burden of Heart Failure, 1990-2023: A Systematic Analysis for the Global Burden of Disease Study 2023. PMID 42814432 — heart diseases, heart failure, heart, cardiovascular diseases, public health, global burden of disease, prevalence, cost of illness, chagas disease | JAMA Cardiol | 2026 | 0 |
Clinical Studies 5
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Cohort/Consortium Investigators 2
Ongoing Clinical Trials
2 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Faster Elimination of HPV Infection and Cervical Cancer Using Concomitant HPV Vaccination and HPV Screening A Demonstration Project in Rwanda NCT06536855 — research design, mortality, condylomata acuminata, vaccines, incidence, uterine cervical neoplasms, neoplasms, vaccination, aged, warts, head and neck neoplasms, alphapapillomavirus, wounds and injuries, dna, papillomavirus infections, infections, human papillomavirus viruses, female, male, women, head, neck | Phase 4 | Not yet recruiting | 2024 |
| Preventing Acquired Resistance Strengthen TB Treatment by Adding Amikacin in the First Treatment Week of Multidrug resistant Tuberculosis NCT05555303 — quality of life, safety, genes, mdr, tuberculosis, multidrug-resistant, syringes, solutions, tuberculosis, amikacin, therapeutics, lidocaine, rifampin | Phase 2 | Recruiting | 2023 |
LeadR Networks
Main global connection map